INTRODUCTION
Ascorbic acid (vitamin C) is essential for normal collagen formation [1, 2] . The isolated enzymes procollagenproline,2-oxoglutarate 4-dioxygenase (proline hydroxylase, EC 1.14.11.2), procollagen-proline,2-oxoglutarate 3-dioxygenase (EC 1.14.11.7), and procollagen-lysine,2-oxoglutarate 5-dioxygenase (lysine hydroxylase, EC 1.14.11.4) require ascorbic acid for maximum activity [3] [4] [5] [6] [7] . However, enzyme activity in intact tissue as a function of intracellular ascorbic acid concentration is unknown. This issue deserves attention for two reasons. First, collagen biosynthesis is indispensable for wound healing [8] . Surprisingly, the amount of ascorbic acid needed to regulate wound healing in humans is unknown. This knowledge could have important consequences for humans undergoing surgery or with traumatic injuries. Second, the relationship between enzyme activity and ascorbic acid concentration could provide new insight to vitamin requirements [9] . We proposed that ascorbic acid requirements could be determined by applying the principles of apparent enzyme kinetics to ascorbic acid-dependent systems in situ [9] . This approach, termed 'in situ kinetics', has been characterized by this laboratory and represents the first quantitative approach to vitamin requirements [9] [10] [11] [12] [13] [14] [15] . Ascorbic acid regulation of collagen biosynthesis in normal human fibroblasts is an ideal application of the principles of in situ kinetics.
An initial step in understanding the relationship between ascorbic acid concentration, enzyme activity and collagen biosynthesis in situ is to investigate intracellular ascorbic acid mass in fibroblasts. However, ascorbic acid mass accumulation within human fibroblasts as a function of external concentration is unknown. The studies in this paper were undertaken to solve this problem, by using an assay for ascorbic acid accumulation developed in this laboratory [16] . (FCCP), 2,4-dinitrophenol (DNP), phloretin, cytochalasin B and phlorizin were dissolved in ethanol; KCN was dissolved in Na+-free BSS. Inhibitors were added to cells for a 15 min preincubation, after which ascorbic acid at the indicated concentration was added to the cultures and incubated for 4 h. Na+-free BSS contained K2HP04 and choline chloride in place of Na2HP04 and NaCl at appropriate concentrations to maintain ionic strength. Cells were incubated in a 5 %-C02 humidified atmosphere at 37°C unless otherwise indicated. After incubation, culture dishes were placed on ice; 250 ,ul ofmedium was removed, added to 500 ,1 of 90 % methanol saturated with EDTA, and frozen on solid CO2 immediately. Cells were then washed with 2 x 2 ml of ice-cold BSS. Intracellular ascorbic acid was extracted with 0.5 ml of ice-cold 600% methanol/I mM EDTA. The methanol/EDTA was gently swirled in the culture wells for 2 min, then removed and immediately frozen on solid CO2. All ascorbic acid samples were stored at -70°C for analysis, and cell monolayers were frozen at -20°C for protein determination.
MATERIALS AND METHODS

Assays
Ascorbic acid extracts were analysed for both mass and radioactivity. Mass was analysed by h.p.l.c. with coulometric electrochemical detection [16] . Purity of the intracellular label was determined by collecting fractions from h.p.l.c. analysis by using a fraction collector with minimal dead volume (LKBPharmacia); radioactivity in each fraction was determined by scintillation spectrometry (Beckman LS-5801). Purity of radiolabel was also determined by comparison of Bq and specific radioactivity of radiolabelled medium with h.p.l.c. analysis of the same medium. Cell protein was determined by the BCA method [17] after solubilization of cell monolayers with 1.0 ml of 1 % CHAPS/0.1 M NaOH.
Results were calculated as pmol of ascorbate/,g of cellular protein, and when indicated were converted into mM amounts. Experimental points represent the mean+ S.D. of at least three samples. Error bars were omitted when the S.D. was less than the size of the symbol. Linear-regression analysis was performed with the kinetic software package ENZFITTER.
Extracellular ascorbic acid For these kinetic data to be valid, external ascorbic acid concentrations should not change during the incubations. We measured a range ofexternal ascorbic acid concentrations at zero time and after 60 min incubations with fibroblasts. Ascorbic acid was stable for 60 min under the conditions used. Ascorbic acid decreased by 10 % every 2 h, in agreement with previous findings [18] . In addition, there was < 10 % oxidation of 3.0 mM external ascorbic acid over 18 h (results not shown).
RESULTS
Intracellular volume of fibroblasts was 11.0 + 2.0 ,u/mg of protein (n = 24). By using these data, intracellular ascorbic acid measured as pmol/,g of protein was expressed as an intracellular concentration when indicated. The uptake of ascorbic acid was linear for several hours, as determined by both scintillation spectrometry and electrochemical detection ( Figure 1 High-affinity ascorbic acid transport As ascorbic acid uptake was linear for several hours, 1 h time points were chosen for kinetic analyses. Fibroblasts were incubated with 1.25-500 gM ascorbic acid; uptake was determined by h.p.l.c. Ascorbic acid uptake occurred as two activities, as evident in both the substrate/velocity curve ( Figure  2a ) and Eadie-Hofstee analyses (inset to Figure 2a ). To separate the two activities, we subtracted the linear portions of the substrate-versus-velocity curves (extracellular ascorbic acid concentrations > 100 #uM) [19] . Lines were constructed from these data points by regression analysis, extrapolated through the ordinate, and recalculated with an ordinate intercept of 0 (r = 0.99). The values determined from these lines were subtracted from the observed uptake at the appropriate substrate concentrations, and the results were replotted (Figure 2b (Figure 2a ). This activity was distinct from the high-affinity transport activity, as seen in the Eadie-Hofstee analyses (inset in Figure 2a ). To describe this second transport activity, human fibroblasts were incubated with 1-10 mM ascorbic acid for 2 h, during which time uptake was linear. Attempts to increase the extracellular ascorbic acid concentrations above 10 mM resulted in toxicity and cell death. Under these conditions ascorbic acid transport was concentration-dependent but non-saturating, with an apparent Km of 5 mM and an apparent Vm.ax of 1.8 mM/h (Figure 3) .
However, the data in Figure 3 did not exclude passive diffusion as a mechanism for the low-affinity activity. To try to distinguish between carrier-mediated transport and passive diffusion, we studied transport in five different cell lines (Figure 4 ). Although these data provided further evidence of two-component transport, they did not allow determination of the mechanism of the non-saturable activity. An apparent diffusion constant of 0.123 h-1 was calculated from the data in Figure 4 . Previous work had indicated that ascorbic acid transport was Na+-dependent [20, 21] . To investigate this possibility, we measured ascorbic acid uptake over a wide range of external ascorbic acid concentrations in the absence or presence of Na+. The high-affinity transporter was Na+-dependent, but the lowaffinity uptake activity was Na+-independent ( Figure 5) .
Ascorbic acid accumulation against a concentration gradient would distinguish a low-affinity transport activity from diffusion. We therefore incubated fibroblasts for 24 h in the absence and presence of Na+ at external ascorbic acid concentrations of 500 and 1000 ,uM. Uptake in the presence of Na+ could be attributed to the actions of both the high-and low-affinity transporter activities, whereas uptake in the absence of Na+ would be attributed to the low-affinity transport activity alone. As shown in Figure 6 , intracellular ascorbic acid concentrations in fibroblasts incubated without Na+ were 0.75 + 0.06 mM and 1.35+0.02 mM for external concentrations of 0.5 mM and 1.0 mM respectively. This indicates the presence of a low-affinity transport activity. Subtracting transport in the absence of Na+ from that in its presence yields transport which is strictly Na+-dependent. The data in Figure 6 Fibroblasts were incubated with 6-300 uM ascorbic acid for 2 h. BSS contained either 150 mM NaCI (0) or 150 mM choline chloride (0). Inset: incubation with 0.3-10 mM ascorbic acid for 2 h. BSS contained either 150 mM NaCI (0) or 150 mM choline chloride (0). Samples were obtained and analysed as described in he Materials and methods section. Figure 3 Ascorbic acid uptake as a function of external ascorbic acid (low-affnity transporter)
Fibroblasts were incubated for 2 h at the indicated ascorbic acid concentrations (insets: Lineweaver-Burk analysis, left; Eadie-Hofstee analysis, right). Ascorbic acid transport by the high-affinity transport activity was subtracted from each data point. Data were filted to apparent Michaelis-Menten kinetics by using a non-linear regression program. Assays were performed as described in the Materials and methods section. Figure 4 , the internal ascorbic acid should have diffused outwards when external vitamin was removed. The lack of outward diffusion is further evidence that diffusion is not a major component of transport in human Table 1 Ascorbic acid transport and dffusion
Fibroblasts were preincubated for 2 h with 3 mM ascorbic acid in normal BSS. Controls were harvested (t= 0). BSS was then replaced with ascorbic acid-free BSS (without Na+) in the remaining wells, and the cells were allowed to incubate for 2 h. At the end of this time, both the cell monolayer (t= 2 h) and the buffer (t = 2 h) were harvested. Ascorbic acid in both the cell monolayer (at t = 0 and 2 h) and the buffer (at t = 2 h) was measured as described in the Materials and methods section. See the text for details.
Ascorbic acid Conditions concn. (mM)
Cell monolayer at t = 0 Cell monolayer at t = 2 h Buffer at t = 2 h 0.85 + 0.05 0.80 + 0.04 0.00053 + 0.00007 Table 2 Effects of Inhibitors on ascorbic acid uptake Fibroblasts were preincubated for 15 min in BSS with the metabolic inhibitor indicated; 1 mM ascorbic acid was then added to the cultures, which were allowed to incubate for 4 h. Extraction was performed as described in the Materials and methods. Percentage ascorbic acid uptake is defined as 100 x the mean of ascorbic acid uptake in the presence of inhibitor divided by the mean of ascorbic acid uptake in the absence of inhibitor (n = 3). for both transport activities. We predicted that if the low-affinity activity was carrier-mediated, it should be sensitive to metabolic inhibitors. The proton uncouplers DNP and FCCP were tested to determine if changes in ApH or AVk would inhibit ascorbic acid transport [22] [23] [24] . In addition, ascorbic acid transport in neutrophils is inhibited by glucose and glucose-transport inhibitors [25] . Cytochalasin B, phloretin and phlorizin are all inhibitors of glucose transport and of ascorbic acid transport in human neutrophils [25] [26] [27] [28] . We predicted that these inhibitors could inhibit transport in fibroblasts. Finally, ascorbic acid uptake was analysed in the presence of KCN to test further for ATP-dependency by the ascorbic acid transporters. Ascorbic acid transport was measured in the absence and presence of Na+. Activity of the low-affinity transporter was determined in the absence of Na+. The Na+-independent low-affinity transporter was inhibited by cytochalasin B, phloretin, DNP, FCCP and KCN (Table 2) . Uptake by the Na+-dependent high-affinity transport was determined by subtracting ascorbic acid uptake in the absence of Na+ from that observed in its presence, yielding only Na+-dependent activity. The high-affinity transporter was inhibited by phloretin, FCCP and DNP, but only marginally by cytochalasin B (Table 2) . Phlorizin had no effect on either transporter (results not shown). These results demonstrate that ascorbic acid transport by both the high-and low-affinity activities is carrier-mediated uptake and not diffusion.
Cytochalasin B and phloretin inhibit glucose transport in fibroblasts [27, 29] . Inhibition of the low-affinity ascorbic acid transporter by these compounds, as well as its Na+-independence, raised the possibility that the low-affinity transport was actually mediated by the glucose transporter. To exclude the possibility that ascorbic acid transport was facilitated transport via the glucose carrier, ascorbic acid transport was determined in the presence of varying concentrations of glucose. Ascorbic acid transport was not inhibited by external glucose concentrations up to 20 mM (Figure 7 ), indicating that glucose and ascorbic acid are transported by separate transport systems.
Ascorbic acid uptake was tested for temperature-dependence at 370 and 0 'C. Ascorbic acid uptake by both the high-and the low-affinity transporters decreased over 10-fold at 0 'C (results not shown).
DISCUSSION
In this paper we demonstrate the uptake of ascorbic acid in human fibroblasts by two transport activities. The first component was a high-affinity active transport activity which had an apparent Km of6 + 2 ,tM and an apparent Vm.ax of203 + 50 ,M/h.
The activity was concentration-and temperature-dependent, saturable, Na+-dependent, inhibited by FCCP, DNP and phloretin, and generated ascorbic acid accumulation against a concentration gradient.
The second transport component was concentration-dependent, but was not saturable at ascorbic acid concentrations up to 10 mM. Attempts to increase the external ascorbic acid concentration above 10 mM resulted in loss of cell adhesion and cell death. Kinetic analysis alone could not distinguish between passive diffusion and carrier-mediated uptake. Nevertheless, there is substantial evidence presented here that the second transport activity is active carrier-mediated transport. Ascorbic acid was transported against a concentration gradient by the low-affinity transporter in the absence of Na+ ( Figure 5 ). Diffusion of intracellular ascorbic acid to the outside was not observed under conditions of 0.8 mM intracellular and zero extracellular ascorbic acid ( Table 1 ), suggesting that the second uptake activity is not diffusion. These findings could not be accounted for by intracellular binding of ascorbic acid, as the vitamin was not bound. Ascorbic acid uptake by the low-affinity transport activity was inhibited by cytochalasin B, phloretin, DNP, FCCP and KCN (Table 2 ). To summarize, accumulation against a concentration gradient, inhibition of the low-affinity transporter by glucose transport and metabolic inhibitors, and the lack of diffusion from intra-to extra-cellular space, demonstrate that the low-affinity transport activity is carriermediated.
The results indicate that the driving force for the high-affinity transporter is the Na+ gradient. Although the data indicate that the low-affinity activity is carrier-mediated active transport, the driving force is unknown. The data suggest that the low-affinity activity is not driven by either the Na+ gradient or intracellular binding. High-affinity transport was inhibited by DNP and FCCP, but not by KCN, whereas the low-affinity activity was inhibited by all three. The inhibition of the high-affinity transporter by the uncouplers may be due more to the alteration of AIR rather than the decrease in available cellular energy. A more complete understanding of the mechanism of transport of the two ascorbic acid transporters awaits isolation ofthe two different activities.
Ascorbic acid transport in human neutrophils is mediated by a two-component transport system which shares several features with ascorbic acid transport in fibroblasts. Transport in both cell types is mediated by two active components, is temperaturesensitive, and is inhibited by phloretin. The high-affinity transport activities have similar kinetic constants, are Na+-dependent, and are inhibited by FCCP. However, cytochalasin B is an effective inhibitor of high-affinity activity in neutrophils, but is substantially less effective in blocking high-affinity transport in fibroblasts. The low-affinity activities in neutrophils and fibroblasts have a similar Km, but the Vmax is 15-fold greater in neutrophils. In contrast with fibroblasts, the low-affinity activity in neutrophils is Na+-dependent and is inhibited by glucose ([14,25] ; Y. Wong, P. Washko and M. Levine, unpublished work) . Reasons for the differences between the two transporters will have to await the isolation of the transport proteins, as above. Received 6 November 1992 /31 March 1993 accepted 28 April 1993 Ascorbic acid accumulation by human fibroblasts is a beginning step in applying the principles of 'in situ kinetics' to collagen biosynthesis. The goal of in situ kinetics is to learn quantitatively how different concentrations of vitamin, in this case ascorbic acid, regulate a biochemical process in situ. The data in this paper provide the first step for studies of in situ kinetics of ascorbic acid in human fibroblasts by quantifying intracellular ascorbic acid as a function of extracellular concentration. The next steps in examining the role of ascorbic acid in collagen biosynthesis, the relationship between ascorbic acid concentration and proline hydroxylation, are in progress.
